Bonita Springs Dialysis is a medicare approved dialysis facility center in Bonita Springs, Florida and it has 16 dialysis stations. It is located in Lee county at 9134 Bonita Beach Rd, Bonita Springs, FL, 34135. You can reach out to the office of Bonita Springs Dialysis at (239) 949-0444. This dialysis clinic is managed and/or owned by Davita. Bonita Springs Dialysis has the following ownership type - Profit. It was first certified by medicare in June, 1999. The medicare id for this facility is 102752 and it accepts patients under medicare ESRD program.
| Name | Bonita Springs Dialysis |
|---|---|
| Location | 9134 Bonita Beach Rd, Bonita Springs, Florida |
| No. of Dialysis Stations | 16 |
| Medicare ID | 102752 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 9134 Bonita Beach Rd, Bonita Springs, Florida, 34135 | |
| (239) 949-0444 | |
| Not Available |
News Archive
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Children in California are more likely to be uninsured than children nationwide, with 1.1 million lacking health coverage in 2011, according to a new study by the Keck School of Medicine of USC. About 11 percent of children lacked insurance last year - and they were less likely to seek medical care than those with coverage, the authors reported. The study, released Wednesday by the California HealthCare Foundation, detailed children's insurance trends over a 10-year period.
A new study led by researchers at Children's Hospital of Philadelphia shows that a set of simple questionnaires can help clinicians and families better evaluate the quality of life of people diagnosed with autism spectrum disorder.
New England Biolabs (NEB) has released a novel DNA polymerase, Q5 High-Fidelity DNA Polymerase, that provides the highest fidelity amplification currently available, while also offering robust amplification across the broadest range of amplicons, including those that are GC- and AT-rich.
› Verified 7 days ago
| NPI Number | 1306813993 |
| Organization Name | Bonita Springs Dialysis |
| Doing Business As | Dva Renal Healthcare Inc |
| Address | 9134 Bonita Beach Rd Se Bonita Springs, Florida, 34135 |
| Phone Number | (239) 949-0444 |
News Archive
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Children in California are more likely to be uninsured than children nationwide, with 1.1 million lacking health coverage in 2011, according to a new study by the Keck School of Medicine of USC. About 11 percent of children lacked insurance last year - and they were less likely to seek medical care than those with coverage, the authors reported. The study, released Wednesday by the California HealthCare Foundation, detailed children's insurance trends over a 10-year period.
A new study led by researchers at Children's Hospital of Philadelphia shows that a set of simple questionnaires can help clinicians and families better evaluate the quality of life of people diagnosed with autism spectrum disorder.
New England Biolabs (NEB) has released a novel DNA polymerase, Q5 High-Fidelity DNA Polymerase, that provides the highest fidelity amplification currently available, while also offering robust amplification across the broadest range of amplicons, including those that are GC- and AT-rich.
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 45 |
News Archive
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Children in California are more likely to be uninsured than children nationwide, with 1.1 million lacking health coverage in 2011, according to a new study by the Keck School of Medicine of USC. About 11 percent of children lacked insurance last year - and they were less likely to seek medical care than those with coverage, the authors reported. The study, released Wednesday by the California HealthCare Foundation, detailed children's insurance trends over a 10-year period.
A new study led by researchers at Children's Hospital of Philadelphia shows that a set of simple questionnaires can help clinicians and families better evaluate the quality of life of people diagnosed with autism spectrum disorder.
New England Biolabs (NEB) has released a novel DNA polymerase, Q5 High-Fidelity DNA Polymerase, that provides the highest fidelity amplification currently available, while also offering robust amplification across the broadest range of amplicons, including those that are GC- and AT-rich.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 85 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 576 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Children in California are more likely to be uninsured than children nationwide, with 1.1 million lacking health coverage in 2011, according to a new study by the Keck School of Medicine of USC. About 11 percent of children lacked insurance last year - and they were less likely to seek medical care than those with coverage, the authors reported. The study, released Wednesday by the California HealthCare Foundation, detailed children's insurance trends over a 10-year period.
A new study led by researchers at Children's Hospital of Philadelphia shows that a set of simple questionnaires can help clinicians and families better evaluate the quality of life of people diagnosed with autism spectrum disorder.
New England Biolabs (NEB) has released a novel DNA polymerase, Q5 High-Fidelity DNA Polymerase, that provides the highest fidelity amplification currently available, while also offering robust amplification across the broadest range of amplicons, including those that are GC- and AT-rich.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bonita Springs Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 86 |
| Hypercalcemia patient months | 588 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 93 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL |
News Archive
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Children in California are more likely to be uninsured than children nationwide, with 1.1 million lacking health coverage in 2011, according to a new study by the Keck School of Medicine of USC. About 11 percent of children lacked insurance last year - and they were less likely to seek medical care than those with coverage, the authors reported. The study, released Wednesday by the California HealthCare Foundation, detailed children's insurance trends over a 10-year period.
A new study led by researchers at Children's Hospital of Philadelphia shows that a set of simple questionnaires can help clinicians and families better evaluate the quality of life of people diagnosed with autism spectrum disorder.
New England Biolabs (NEB) has released a novel DNA polymerase, Q5 High-Fidelity DNA Polymerase, that provides the highest fidelity amplification currently available, while also offering robust amplification across the broadest range of amplicons, including those that are GC- and AT-rich.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 99 |
| Patient months included in arterial venous fistula and catheter summaries | 528 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Children in California are more likely to be uninsured than children nationwide, with 1.1 million lacking health coverage in 2011, according to a new study by the Keck School of Medicine of USC. About 11 percent of children lacked insurance last year - and they were less likely to seek medical care than those with coverage, the authors reported. The study, released Wednesday by the California HealthCare Foundation, detailed children's insurance trends over a 10-year period.
A new study led by researchers at Children's Hospital of Philadelphia shows that a set of simple questionnaires can help clinicians and families better evaluate the quality of life of people diagnosed with autism spectrum disorder.
New England Biolabs (NEB) has released a novel DNA polymerase, Q5 High-Fidelity DNA Polymerase, that provides the highest fidelity amplification currently available, while also offering robust amplification across the broadest range of amplicons, including those that are GC- and AT-rich.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Children in California are more likely to be uninsured than children nationwide, with 1.1 million lacking health coverage in 2011, according to a new study by the Keck School of Medicine of USC. About 11 percent of children lacked insurance last year - and they were less likely to seek medical care than those with coverage, the authors reported. The study, released Wednesday by the California HealthCare Foundation, detailed children's insurance trends over a 10-year period.
A new study led by researchers at Children's Hospital of Philadelphia shows that a set of simple questionnaires can help clinicians and families better evaluate the quality of life of people diagnosed with autism spectrum disorder.
New England Biolabs (NEB) has released a novel DNA polymerase, Q5 High-Fidelity DNA Polymerase, that provides the highest fidelity amplification currently available, while also offering robust amplification across the broadest range of amplicons, including those that are GC- and AT-rich.
› Verified 7 days ago